Richard M. Bergenstal
HealthPartners(US)
Publications by Year
Research Areas
Diabetes Treatment and Management, Diabetes Management and Research, Diabetes, Cardiovascular Risks, and Lipoproteins, Metabolism, Diabetes, and Cancer, Hyperglycemia and glycemic control in critically ill and hospitalized patients
Most-Cited Works
- → Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes(2016)7,101 cited
- → Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes(2013)2,508 cited
- → Design of the liraglutide effect and action in diabetes: Evaluation of cardiovascular outcome results (LEADER) trial(2013)242 cited
- → Clinical Application of Incretin-Based Therapy: Therapeutic Potential, Patient Selection and Clinical Use(2009)173 cited
- → EXamination of CArdiovascular OutcoMes with AlogliptIN versus Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome (EXAMINE)(2011)150 cited
- → Trends in Insulin Use and Diabetes Control in the U.S.: 1988–1994 and 1999–2012(2015)108 cited
- → Identifying Trends in Undiagnosed Diabetes in U.S. Adults by Using a Confirmatory Definition(2017)74 cited
- → Cardiovascular Mortality in Patients With Type 2 Diabetes and Recent Acute Coronary Syndromes From the EXAMINE Trial(2016)63 cited
- → Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: T he EXAMINE trial(2017)57 cited